The number of people with the respiratory syncytial virus, or RSV, has surged, with cases hitting a two-year high, according to CDC data.
November 3, 2022, 8:46 PMThe number of people with the respiratory syncytial virus, or RSV, has surged, with cases hitting a two-year high, according toRSV is twice as high among people of all ages at this point this year compared to last year, with the U.S. seeing more than twice as many cases per week, according to ABC News contributor Dr. John Brownstein, an epidemiologist and chief innovation officer at Boston Children's Hospital.
"Those respiratory viruses have been on a hiatus because kids have been somewhat isolated and have returned to normal school," he said.While RSV affects children and adults, it's particularly dangerous for kids under 1-year-old and seniors 65 years old and older. Washington, D.C. and 17 states, including Tennessee, Connecticut, Delaware, Arizona and Rhode Island, are seeing between 80% and 90% of pediatric hospitalizations bed capacity, according to HHS data. Maine sits at 102%, which means it has more patients than beds available.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Strong RSV vaccine data lifts hopes after years of futilityNew research shows vaccinating pregnant women helped protect their newborns from the common but scary respiratory virus called RSV that fills hospitals with wheezing babies each fall.
Baca lebih lajut »
RSV vaccine may be close as Chicago pediatric hospitalizations reach highest level in yearsPfizer says its RSV vaccine is safe for pregnant women and effective in helping protect their babies as the virus hits Chicago hard.
Baca lebih lajut »
RSV vaccine under development as pediatric cases surge at SoCal hospitalsPfizer's vaccine for RSV might be only a year away, providing some hope as cases surge at SoCal hospitals this year.
Baca lebih lajut »
Strong RSV vaccine data lifts hopes after years of futilityNew research shows vaccinating pregnant women helped protect their newborns from the common but scary respiratory virus called RSV that fills hospitals with wheezing babies each fall.
Baca lebih lajut »
Strong RSV Vaccine Data Lifts Hopes After Years of FutilityPfizer announced Tuesday that a large international study found vaccinating moms-to-be was nearly 82% effective at preventing severe cases of RSV in their babies’ most vulnerable first 90 days of life. At age 6 months, the vaccine still was proving 69% effective against serious illness.
Baca lebih lajut »